Oryzon Genomics is a clinical-stage biopharmaceutical company based in Spain that works on epigenetics-based medicines. It develops small-molecule drugs that target epigenetic enzymes, with programmes in oncology and in disorders of the central nervous system. Its pipeline includes compounds studied in blood cancers and in neurodegenerative and neurodevelopmental conditions. The company carries out its own research and clinical development and works with partners and academic groups to advance its drug candidates through testing.
The shares are listed on the Madrid Exchange in Spain under the code ORY, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #188 of 236 on the Madrid Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Spain yet.
TrendWeak
23/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-13.2%
From 52-week high-28.5%
MomentumWeak
23/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-15.3%
6-month return-10.5%
12-month, skipping last month-14.1%
Stability (higher is calmer)Weak
29/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)33.5%
Worst drawdown, 1 year (smaller is calmer)-28.7%
LiquidityStrong
70/100
Trades actively.
See the numbers →
Avg daily value traded0.43M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Spain when fundamentals data for this market is added. All Spain stocks.
52-wk range 2.480 – 3.745Daily closes, split-adjusted
Signals
50-day average2.744
200-day average2.916
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.071
Technical summary
Daily
Strongly bearish
2 bullish · 2 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
2.58
Bearish
EMA 10
2.59
Bearish
SMA 20
2.65
Bearish
EMA 20
2.63
Bearish
SMA 50
2.74
Bearish
EMA 50
2.73
Bearish
SMA 100
2.87
Bearish
EMA 100
2.81
Bearish
SMA 200
2.92
Bearish
EMA 200
2.86
Bearish
Oscillators (daily)
RSI (14)
35.74
Neutral
MACD (12, 26)
-0.06
Bearish
Momentum (12)
-6.92
Bearish
Stochastic %K (14)
18.12
Bullish
Williams %R (14)
-81.88
Bullish
CCI (20)
-85.91
Neutral
Pivot points (classic, last session)
S3
2.44
S2
2.49
S1
2.51
Pivot
2.55
R1
2.57
R2
2.62
R3
2.64
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
